Atrial Fibrillation, Atrial Flutter
Conditions
Keywords
Atrial Fibrilation, Antithrombotic therapy, Atrial Flutter
Brief summary
Follow a representative sample of Latin American patients diagnosed with atrial fibrillation to set data on demographic characteristics, documenting antithrombotic therapy, describe the INR control level of VKA users, discontinuation rates and clinical outcomes, such as stroke, hemorrhage and death
Detailed description
Patients will be followed 6 months and 1 year after the baseline visit and will be collected data of antithrombotic therapy, laboratory data, discontinuation rates of antithrombotic therapy and clinical outcomes.
Interventions
OTHERPatient Registry Data
To set data on demographic characteristics,documenting antithrombotic therapy, describe the INR control level of VKA users, discontinuation rates and clinical outcomes, such as stroke, hemorrhage and death.
Sponsors
Brazilian Clinical Research Institute
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age \> 18 years-old that signed informed consent; * Atrial Fibrillation or Atrial Flutter at the time of inclusion documented in source document; * If the patient is not in atrial fibrillation or Atrial Flutter rhythm, s/he should have 2 electrographic records, at least 15 days apart between them, with one of them being performed within the last 6 months before enrollment (AF may be documented by 12-lead ECG, Holter monitor-24h);
Exclusion criteria
* Patients who did not agree to participate. * Patients without possibility of monitoring for one year.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| INR control rate | 12 months |
| Oral anticoagulation discontinuation rate | 12 months |
| Percentage of death | 12 months |
| Percentage of stroke | 12 months |
| Percentage of systemic embolism | 12 months |
| Percentage of myocardial infarction | 12 months |
| Percentage of major bleeding | 12 months |
| Percentage of electrical cardioversion | 12 months |
| Percentage of percutaneous ablation of AF | 12 months |
| Percentage of atrioventricular junction ablation | 12 months |
| Percentage of patients that need of pacemaker implantation | 12 monts |
| Percentage of other cardiovascular hospitalization | 12 months |
Countries
Argentina, Brazil, Colombia, Mexico
Outcome results
None listed